Denali Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Denali Therapeutics Inc. has filed 787 SEC EDGAR filings since 08 Sep 2017

SEC filing history

Showing 126-150 of 787 matching filings.

Per page
25
Current page
6
4

FORM 4

Filing date
26 Nov 2024
Reporting date
22 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Nov 2024
Reporting date
11 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Nov 2024
Reporting date
07 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Nov 2024
Reporting date
07 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90223

SEC SCHEDULE 13G

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90223

SC 13G/A filing

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90223

SC 13G/A filing

Filing date
08 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90223

SEC SCHEDULE 13G

Filing date
08 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90223

SC 13G/A

Filing date
07 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
07 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Nov 2024
Reporting date
01 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Oct 2024
Reporting date
18 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90223

SC 13G/A filing

Filing date
21 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
18 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Oct 2024
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
30 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Sep 2024
Reporting date
13 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
13 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Sep 2024
Reporting date
03 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Aug 2024
Reporting date
20 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .